` 2137 (Brii Biosciences Ltd) vs Hang Seng (Hong Kong) Comparison - Alpha Spread

2137
vs
H
Hang Seng (Hong Kong)

Over the past 12 months, Brii Biosciences Ltd has significantly outperformed Hang Seng (Hong Kong), delivering a return of +125% compared to the Hang Seng (Hong Kong)'s +49% growth.

Stocks Performance
2137 vs Hang Seng (Hong Kong)

Loading
2137
Hang Seng (Hong Kong)
Add Stock
www.alphaspread.com

Performance Gap
2137 vs Hang Seng (Hong Kong)

Loading
2137
Hang Seng (Hong Kong)
Difference
www.alphaspread.com

Performance By Year
2137 vs Hang Seng (Hong Kong)

Loading
2137
Hang Seng (Hong Kong)
Add Stock

Competitors Performance
Brii Biosciences Ltd vs Peers

Hang Seng (Hong Kong)
2137
ABBV
AMGN
GILD
VRTX
Add Stock

Brii Biosciences Ltd
Glance View

Market Cap
1.5B HKD
Industry
Biotechnology

Brii Biosciences Ltd. is a holding company, which engages in the research and development of medicines. The company is headquartered in Beijing, Beijing and currently employs 113 full-time employees. The company went IPO on 2021-07-13. The Company’s products are applied in infectious diseases, such as hepatitis B virus (HBV), human immunodeficiency virus (HIV), multi-drug resistant (MDR) or extensive drug resistant (XDR) gram-negative infections, and other illnesses, such as the central nervous system (CNS) diseases, which have significant public health burdens. The firm is also developing therapies for COVID-19 and other diseases.

Intrinsic Value
Not Available
Back to Top